WILLIAM LEWIS: Open Payments
NPI 1003584640 · WEST DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$391 in 21 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $301 · 2025 $391
Food & beverage: $391
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 6 | $122 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| MDD US Operations, LLC | 2 | $40 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| ABBVIE INC. | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| Itamar Medical Inc | 1 | $15 |
Products named: REXULTI, Qelbree, Auvelity, VRAYLAR, SPRAVATO, CAPLYTA, UZEDY, INGREZZA.
Industry payments across IA — which companies pay providers there.
